Breaking News
0

Amgen Inc (AMGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Amgen's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
178.36 +1.89    +1.07%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
178.36
0.00
0.00%
16:33:45 - Real-time Data
Type: Equity
Market: United States
ISIN: US0311621009 
CUSIP: 031162100
  • Volume: 2,676,828
  • Bid/Ask: 178.36 / 179.50
  • Day's Range: 176.51 - 179.57
Amgen 178.36 +1.89 +1.07%

AMGN Overview

 
Information about the Amgen Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close176.47
Day's Range176.51 - 179.57
Revenue28.4B
Open176.71
52 wk Range152.16 - 201.23
EPS11.56
Volume2,676,828
Market Cap116.66B
Dividend (Yield)5.28 (3.02%)
Average Vol. (3m)4,811,198
P/E Ratio15.27
Beta1.36
1-Year Change12.75%
Shares Outstanding661,706,007
Next Earnings DateJul 23, 2018
What is your sentiment on Amgen?
or
Market is currently closed. Voting is open during market hours.

Amgen Inc News


Entera Bio Re-Enters IPO Process
Entera Bio Re-Enters IPO Process
By Seeking Alpha - 3 hours ago

Entera Bio has filed an amended registration statement reviving its IPO efforts. The firm is advancing a pipeline of hypoparathyroidism and osteoporosis treatme

Amgen Wins Another FDA Approval
Amgen Wins Another FDA Approval
By 247wallst - 5 hours ago

Amgen shares made a slight gain on Tuesday after it was announced that the FDA approved its treatment of glucocorticoid-induced osteoporosis in men and women at high risk of...

FDA OKs new indication for Amgen's Prolia
FDA OKs new indication for Amgen's Prolia
By Seeking Alpha - May 21, 2018

The FDA approves the use of Amgen's (AMGN) Prolia (denosumab) to treat glucocorticoid-induced osteoporosis in men and women at high risk of fracture, the f

Amgen Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Neutral Buy Buy Strong Buy
Technical Indicators Strong Sell Strong Sell Strong Buy Strong Buy BUY
Summary Strong Sell Sell Strong Buy Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Completed Patterns
Three Outside Down 30 1 May 22, 2018 03:00PM
Deliberation Bearish 1D 2 May 18, 2018
Engulfing Bearish 30 2 May 22, 2018 02:30PM
Engulfing Bearish 1W 3 Apr 29, 2018
Upside Gap Three Methods 1D 5 May 15, 2018

Amgen Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 178.36 178.36 179.50 2,676,828 +1.07% USD 15:59:59  
  Mexico 3,523.23 0.00 0.00 843 +0.23% MXN 13:07:19  
  Switzerland 170.00 0.00 0.00 0 0.00% CHF 02/05  
  Berlin 150.00 152.02 152.33 0 -0.69% EUR 02:08:00  
  Frankfurt 151.38 152.04 152.38 965 +0.92% EUR 12:38:00  
  Xetra 151.09 151.17 153.07 939 +1.38% EUR 11:35:00  
  TradeGate 151.77 151.16 151.61 1,519 +1.33% EUR 15:25:00  
  Munich 149.41 0.00 0.00 0 +0.03% EUR 02:04:00  
  Stuttgart 151.39 0.00 0.00 0 +1.45% EUR 15:45:00  
  BM&FBovespa 648.16 0.00 0.00 0 0.00% BRL 21/05  
  Hong Kong 1,000.00 0.00 0.00 0 +0.00% HKD 05/04  
  Vienna 150.320 0.000 0.000 0 +0.00% EUR 18/05  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Micron 59.03 60.50 58.30 +3.55 +6.40% 110.10M 15:59:59  
  Tesla 275.01 288.00 273.42 -9.48 -3.33% 8.85M 15:59:59  
  Facebook 183.80 185.42 183.43 -0.69 -0.37% 12.19M 15:59:59  
  Apple 187.28 188.88 186.78 -0.35 -0.19% 14.91M 15:59:59  
  General Electric 15.29 15.59 15.29 +0.03 +0.20% 64.12M 15:59:59  
  Amazon.com 1,581.40 1,589.89 1,575.25 -4.06 -0.26% 2.03M 15:59:59  
  NVIDIA 242.70 245.80 240.25 -1.54 -0.63% 12.84M 15:59:59  
  Netflix 331.62 336.63 331.15 -0.20 -0.06% 5.90M 15:59:59  
  Alibaba 195.87 198.63 195.70 -1.77 -0.90% 9.64M 15:59:59  
  Chesapeake Energy 4.540 5.000 4.460 -0.070 -1.52% 138.49M 15:59:59  

Amgen Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

20800

Equity Type

ORD

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
National Futures Association (United States), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Australian Securities and Investments Commission (Australia), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Board of India (India), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong), Securities Investor Protection Corporation (United States) $10000 Start Trading
U.S. Commodity Futures Trading Commission (United States) Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $2000 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AMGN Comments

Write your thoughts about Amgen Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
anshum gupta
anshum gupta May 16, 2016 3:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Possibility of a correction from the current levels, but it becomes a good buy in between 144.5-147.5 for the targets of 157.5/159.35/173.3/180. If kept from a longer term perspective, then ultimate target of 210 and above is possible. Keep a stop loss of below 137.5 on a monthly closing basis. Happy investing!!!!
Reply
1 0
Christian Heine
Christian Heine May 16, 2016 3:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The correction should have occured in after trades...speculative attack..
Reply
0 0
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email